Zyceva Tablets contain erlotinib, a prescription anticancer medicine belonging to the tyrosine kinase inhibitor class. It is used under specialist medical supervision for certain types of cancer, particularly specific cases of non-small cell lung cancer (NSCLC) and, in combination with other treatment, certain advanced pancreatic cancers. Erlotinib works by blocking signals associated with the epidermal growth factor receptor (EGFR), which can contribute to the growth and multiplication of cancer cells. Patients should use Zyceva only when prescribed by a qualified oncologist or healthcare professional. The appropriate strength and treatment schedule depend on the cancer type, test results, overall health, other medicines, and response to treatment. Zyceva Tablets Strengths Zyceva Tablets are available in the following strengths: Zyceva 100 mg Tablet – contains erlotinib 100 mg. Zyceva 150 mg Tablet – contains erlotinib 150 mg. Indian medicine listings identify both 100 mg and 150 mg tablet strengths. The strength prescribed should not be changed independently. Your doctor may select or adjust the dose according to your diagnosis, treatment response, side effects, liver function, and other clinical factors. What Is Zyceva Tablet Used For? Zyceva contains erlotinib and may be prescribed for specific patients with EGFR mutation-positive metastatic non-small cell lung cancer. Erlotinib has also been used with gemcitabine for locally advanced, unresectable, or metastatic pancreatic cancer. The exact indication depends on the patient's clinical assessment and applicable treatment guidelines. Because cancer treatment is highly individualized, Zyceva should not be started based only on information found online. How Does Zyceva Work? Erlotinib inhibits EGFR tyrosine kinase activity. EGFR is involved in signalling pathways that can promote cancer-cell growth. By interfering with these signals, erlotinib can slow the growth or spread of certain cancer cells that depend on EGFR signalling. How Should Zyceva Be Taken? Take Zyceva exactly as prescribed by your doctor. Do not change the dose, stop treatment, or take additional tablets without medical advice. Erlotinib is generally taken on an empty stomach, and your healthcare professional can provide specific instructions about timing and food. Tell your doctor about all medicines, supplements, and medical conditions before starting treatment. Particular attention may be required when using medicines that affect stomach acidity because they can affect erlotinib absorption. Frequently Asked Questions About Zyceva Tablets 1. What is Zyceva Tablet? Zyceva Tablet is an erlotinib-containing prescription anticancer medicine used for specific cancer indications. 2. What are the strengths of Zyceva? The commonly listed strengths are 100 mg and 150 mg, containing erlotinib 100 mg and 150 mg respectively. 3. Is Zyceva used for lung cancer? Yes. Erlotinib may be prescribed for specific patients with EGFR mutation-positive metastatic NSCLC. 4. Can Zyceva be used for pancreatic cancer? Erlotinib may be used with gemcitabine for certain patients with locally advanced, unresectable, or metastatic pancreatic cancer. 5. Can I choose between Zyceva 100 mg and 150 mg myself? No. The appropriate strength must be determined by your treating doctor. 6. Is Zyceva available without a prescription? Zyceva is a prescription medicine. Patients should obtain and use it only under appropriate medical supervision. Medical Disclaimer: This page provides general educational information and does not replace advice from an oncologist or other qualified healthcare professional. Do not self-medicate or change cancer treatment based on online information.